Search
DPP-IV inhibitors are a new class of anti-diabetic drugs, and vigliglitin is a representative drug of DPP-IV inhibitors.
Vildagliptin exerts hypoglycemic effects by inducing and promoting the biosynthesis and secretion of insulin, inhibiting β apoptosis, inhibiting the secretion of glucagon, reducing food intake, etc., and can reverse the deterioration of islet function in diabetic patients while controlling blood sugar, showing good application prospects.
| ITEMS | Specifications | Results |
| Appearance | Off-white to white crystalline powder | Complies |
| Specific rotation | -82.0~ -92.0 | -87.0 |
| Loss on drying | ≤0.5% | 0.10% |
| Residue on ignition | ≤0.1% | 0.03% |
| Assay(HPLC) | ≥99.0% | 99.4% |
| Product parameters | |
| Cas number: | 274901-16-5 |
| Appearance: | Off-white to white crystalline powder |
| Purity: | 99%min |
| Package details: | 1kg/foilbag; 25kg/drum |
| Brand: | Fortunachem |

Fortunachem Provides Not Only Professional Chemical Products But Also Professional Help
Keeping you up-to-date with all the latest information, news, and events about Fortunachem!
Quick Links
Add:
E-mail:
English
Español
français
العربية